Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)

7.84
0.00
(0.00%)
At close: 3:04:33 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Yingchun Wang Deputy GM & Director -- -- 1977
Mr. Guo Lin Chai Deputy General Manager -- -- 1967
Mr. Xiao Yun Feng Deputy General Manager -- -- 1969
Mr. Junhui Wang Secretary of the Board -- -- 1984

LanZhou Foci Pharmaceutical Co.,Ltd.

No. 2289 Huashan Road
Lanzhou New District
Lanzhou, 730000
China
86 93 1362 889 https://www.fczy.com
Sector: 
Healthcare

Description

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the Min Shan and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing and selling of Chinese herbal medicine pieces; and production and sales of medical devices such as protective masks. In addition, the company exports its products. LanZhou Foci Pharmaceutical Co.,Ltd. was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. is a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd.

Corporate Governance

LanZhou Foci Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 25, 2024 at 12:00 AM UTC

Ex-Dividend Date